This report discusses the relationship between TB and sustainable development, and advocates for increased dialogue and action among TB partners.
This bilingual publication puts a human face on the TB epidemic and depicts the suffering of people affected by this disease through images and interviews. The publication also describes the efficacy of the DOTS program in fighting TB.
This report describes World TB Day events and activities that took place on March 24, 2000 to raise public awareness about the extent of the TB epidemic in various countries and territories around the world.
This book presents five papers that were used as background to a workshop on "Improving TB Drug Management: Accelerating DOTS Expansion" on June 2002, in Washington, DC. The papers address the weaknesses in drug management programs of certain countries and provide a framework for strengthening these programs through country-specific action plans.
This report provides suggestions that may facilitate increased involvement of the National Tuberculosis Control Program (NTP) in health sector reform, encourage increased technical input into health systems' planning, and promote the strategic positioning of TB control in the context of changing health systems.
This report assesses the effectiveness, cost, and cost-effectiveness of the public-private mix DOTS (PPM-DOTS) program in pilot projects in Hyderabad and Delhi, India.
This report presents a regional framework for addressing TB/HIV co-infection in the Western Pacific that is adapted to the epidemiological profile and health service system of the region and identifies areas in which both programs can complement each other to address TB/HIV.
This guideline sets forth the framework to guide European countries in developing their national plan for reducing TB/HIV morbidity and mortality. The framework sets out the rationale for effective collaboration between HIV/AIDS and tuberculosis national programs.
This report explains the European DOTS Expansion plan to control TB. The plan highlights country needs and resource gaps, emphasizing collaboration with the governments of endemic countries, national and international agencies, and nongovernmental organizations (NGOs). The aim is to stimulate social and political commitment to achieving the global TB targets as part of the overall health system. The plan is based on two principles: the development of national DOTS expansion plans and partnership-building to control TB.
This booklet answers questions about the 4-drug fixed-dose combinations containing 150 mg rifampicin, 75 mg isoniazid, 400 mg pyrazinamide, and 275 mg ethambutol that were added to the WHO Model List of Essential Drugs for the treatment of TB.
